Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-25 @ 2:36 AM
NCT ID:
NCT04283734
Eligibility Criteria:
Inclusion Criteria:
* Age higher than 18 years old.
* Sign of inform consent
* Patients with at least a vessel with angiographic significant lesion (long/sequential or diffuse lesion) \>/= 25 mm of length where the percutaneous strategy is going to be the choice strategy.
* Patients with stable angina, NSTEMI or STEMI (non culprit vessel)
Exclusion Criteria:
* Patients with Acute Coronary Syndrome with non optimal result of culprit vessel (final TIMI flow \< TIMI III, non-reflow phenomenon during the treatment, residual coronary dissection, lost or compromise of significant side branch).
* Acute Coronary Syndrome and Left Ventricular Ejection Fraction lower than 45%.
* Live expectancy lower than 12 months.
* Patients with severe aortic stenosis.
* Contraindication for dual anti platelet therapy during at least 12 months.
* Patients with indication of bypass surgery in base to Heart Team decision.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04283734
Study Brief:
Protocol Section:
NCT04283734